MARK E. TRYNISKI - 05 Nov 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
Sarah M Oliker for Mark E. Tryniski by Power of Attorney
Issuer symbol
CNMD
Transactions as of
05 Nov 2021
Net transactions value
-$1,182,424
Form type
4
Filing time
08 Nov 2021, 19:59:52 UTC
Previous filing
16 Sep 2021
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $253,895 +4,892 +59% $51.90 13,188 05 Nov 2021 Direct
transaction CNMD Common Stock Sale $749,986 -4,792 -36% $156.51 8,396 05 Nov 2021 Direct F1
transaction CNMD Common Stock Sale $15,711 -100 -1.2% $157.11 8,296 05 Nov 2021 Direct
transaction CNMD Common Stock Options Exercise $234,633 +3,399 +41% $69.03 11,695 05 Nov 2021 Direct
transaction CNMD Common Stock Sale $453,517 -2,899 -25% $156.44 8,796 05 Nov 2021 Direct F2
transaction CNMD Common Stock Sale $78,530 -500 -5.7% $157.06 8,296 05 Nov 2021 Direct F3
transaction CNMD Common Stock Options Exercise $230,707 +2,886 +35% $79.94 11,182 05 Nov 2021 Direct
transaction CNMD Common Stock Sale $373,256 -2,386 -21% $156.44 8,796 05 Nov 2021 Direct F4
transaction CNMD Common Stock Sale $78,474 -500 -5.7% $156.95 8,296 05 Nov 2021 Direct F5
transaction CNMD Common Stock Options Exercise $136,271 +1,843 +22% $73.94 10,139 05 Nov 2021 Direct
transaction CNMD Common Stock Sale $272,750 -1,743 -17% $156.48 8,396 05 Nov 2021 Direct F6
transaction CNMD Common Stock Sale $15,705 -100 -1.2% $157.05 8,296 05 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -4,892 -100% $0.000000* 0 05 Nov 2021 Common Stock 4,892 $51.90 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -3,399 -100% $0.000000* 0 05 Nov 2021 Common Stock 3,399 $69.03 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -2,886 -100% $0.000000* 0 05 Nov 2021 Common Stock 2,886 $79.94 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1,843 -100% $0.000000* 0 05 Nov 2021 Common Stock 1,843 $73.94 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.82 to $156.81. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.83 to $157.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.81 to $156.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.86 to $157.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F7 The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
F8 The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.